Image (3f43a0a4 1606 4d45 95c0 46b73e504010 01)
Famotidine Tablet, Film Coated
Product Images NDC 64980-623
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Famotidine (NDC 64980-623). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Rising Pharma Holdings, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Image (3f43a0a4 1606 4d45 95c0 46b73e504010 02)
This text is not-readable.*
Image (3f43a0a4 1606 4d45 95c0 46b73e504010 03)
This is a description for Famotidine tablets, USP, containing 100 tablets with each film-coated tablet containing 40mg of Famotidine USP. The usual dosage information is available in the package insert. It should be stored at 20° to 25°C (68° to 77°F) with excursions permitted to 15° to 30°C (59° to 86°F). The tablets should be dispensed in a USP tight, light-resistant container. The tablets are manufactured by Graviti Pharmaceuticals Pvt. Ltd. in Telangana, India. The distribution is done by Rising Pharma Holdings, Inc. in East Brunswick, NJ 08816.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
